Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fycompa in Catamenial Epilepsy
NCT05201703Phase 4Terminated
- Sponsor
- University of Florida
- Start
- Mar 2022
- Primary completion
- Dec 2023
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of perampanel in catamenial epilepsy (CE), sponsored by University of Florida. Started Mar 2022; status: terminated.
02
Drugs
perampanel
03
Conditions
catamenial epilepsy (CE)
Beyond the preview
Go deeper on NCT05201703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05201703.